CONSEQUENCES OF HUMAN PIT-1 AND GH PROMOTER MUTATIONS
CONSEQUENCES OF HUMAN PIT-1 AND GH PROMOTER MUTATIONS
批准号:
2145496
负责人:
JOHN S. PARKS
金额:
$18.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 1996-12-31
关键词:
DNA replication HeLa cells autosomal dominant trait autosomal recessive trait child (0-11) developmental genetics family genetics gel mobility shift assay gene mutation genetic polymorphism genetic promoter element homeobox genes human genetic material tag human tissue hypopituitarism nucleic acid sequence pituitary dwarfism polymerase chain reaction prolactin protein structure function site directed mutagenesis somatotropin thyrotropin transcription factor transfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Pituitary growth hormone production is essential for normal postnatal
growth. Recent studies in the applicant's laboratory have linked mutations
of the Pit-1 gene to a human growth disorder involving deficiencies of the
anterior pituitary hormones growth hormone, prolactin and thyrotropin.
Humans with a substitution of proline for alanine at amino acid 158 differ
from Snell dwarf mice with a mutation at amino acid 261 in that they have
normal anterior pituitary size and only mild thyrotropin deficiency. The
observation that an alteration in the POU-specific domain of Pit-1
eliminates transcriptional activation of its known target genes growth
hormone and prolactin, with minimal impairment of binding to these genes
and no impairment of anterior pituitary growth was not predicted by
studies of mutant Pit-1 proteins produced in the laboratory. It suggests
that sequence variation in the Pit-1 gene and its target gene promoters
may account for a broader spectrum of human growth disorders. The
proposed studies address this issue through examination of Pit-1 gene
sequence in a large number of families with combined GH, Prl and TSH
deficiencies, autosomal recessive isolated growth hormone deficiency, or
autosomal dominant isolated growth hormone deficiency. The alternative
possibility of an abnormality of regulatory elements in the growth hormone
gene promoter is addressed through sequencing of the growth hormone
promoter in families with autosomal recessive isolated growth hormone
deficiency. Sequence variation is detected through polymerase chain
reaction amplification of genomic DNA or cDNA and localized through direct
DNA sequencing. The functional consequences of Pit-1 gene and growth
hormone promoter sequence abnormalities are assessed by mobility shift
DNA-binding assays, co-transfection of activator and reporter gene
constructs in HeLa cells, and assays for activity of wild type and mutant
Pit-1 in Adenovirus DNA replication assays. Studies of DNA sequence
variation in children with severe disorders of growth are accompanied by
studies of polymorphic variation in the same sequences among subjects at
the extremes for normal growth. This project will define the importance of
variations in Pit-1 and its target gene sequences in the pathogenesis of
anterior pituitary hormone deficiency and in the generation of differences
in patterns of growth among normal individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INHERITED GROWTH HORMONE DEFICIENCY
-
批准号:6586037
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:JOHN S. PARKS
-
依托单位:
INHERITED GROWTH HORMONE DEFICIENCY
-
批准号:6565742
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:JOHN S. PARKS
-
依托单位:
INHERITED GROWTH HORMONE DEFICIENCY
-
批准号:6415360
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2000
-
负责人:JOHN S. PARKS
-
依托单位:
SAFETY OF NUTROPIN LIQUID--SOMATOTROPIN INJECTION
-
批准号:6113151
-
项目类别:
-
资助金额:$3.88万
-
财政年份:1998
-
负责人:JOHN S. PARKS
-
依托单位:
INHERITED GROWTH HORMONE DEFICIENCY
-
批准号:6113173
-
项目类别:
-
资助金额:$3.88万
-
财政年份:1998
-
负责人:JOHN S. PARKS
-
依托单位:
LUPRON TREATMENT OF PROGRESSIVE PRECOCIOUS PUBERTY
-
批准号:6113150
-
项目类别:
-
资助金额:$3.88万
-
财政年份:1998
-
负责人:JOHN S. PARKS
-
依托单位:
GROWTH HORMONE GENE STRUCTURE--BIOINACTIVE HUMAN GROWTH HORMONE SYNDROME
-
批准号:6113149
-
项目类别:
-
资助金额:$3.88万
-
财政年份:1998
-
负责人:JOHN S. PARKS
-
依托单位:
GROWTH HORMONE GENE STRUCTURE--BIOINACTIVE HUMAN GROWTH HORMONE SYNDROME
-
批准号:6274383
-
项目类别:
-
资助金额:$3.57万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
PIT-1 GENE AND GH PROMOTOR MUTATIONS
-
批准号:6274411
-
项目类别:
-
资助金额:$3.57万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
MULTICENTER SAFETY STUDY OF NUTROPIN LIQUID (SOMATROPIN INJECTION)
-
批准号:6244321
-
项目类别:
-
资助金额:$3.62万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
INHERITED GROWTH HORMONE DEFICIENCY
-
批准号:6244359
-
项目类别:
-
资助金额:$3.62万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
SAFETY AND EFFICACY OF RHGH IN UNTREATED PATIENTS WITH GH DEFICIENCY
-
批准号:6244329
-
项目类别:
-
资助金额:$3.62万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
INHERITED GROWTH HORMONE DEFICIENCY
-
批准号:6274407
-
项目类别:
-
资助金额:$3.57万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
LUPRON TREATMENT OF PROGRESSIVE PRECOCIOUS PUBERTY
-
批准号:6274384
-
项目类别:
-
资助金额:$3.57万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
LUPRON TREATMENT OF PROGRESSIVE PRECOCIOUS PUBERTY
-
批准号:6244320
-
项目类别:
-
资助金额:$3.62万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
GROWTH HORMONE GENE STRUCTURE--BIOINACTIVE HUMAN GROWTH HORMONE SYNDROME
-
批准号:6244319
-
项目类别:
-
资助金额:$3.62万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
MULTICENTER SAFETY STUDY OF NUTROPIN LIQUID (SOMATROPIN INJECTION)
-
批准号:6274385
-
项目类别:
-
资助金额:$3.57万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
PIT-1 GENE AND GH PROMOTOR MUTATIONS
-
批准号:6244365
-
项目类别:
-
资助金额:$3.62万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
SAFETY AND EFFICACY OF RHGH IN UNTREATED PATIENTS WITH GH DEFICIENCY
-
批准号:6274389
-
项目类别:
-
资助金额:$3.57万
-
财政年份:1997
-
负责人:JOHN S. PARKS
-
依托单位:
CONSEQUENCES OF HUMAN PIT-1 AND GH PROMOTER MUTATIONS
-
批准号:2145498
-
项目类别:
-
资助金额:$19.55万
-
财政年份:1994
-
负责人:JOHN S. PARKS
-
依托单位:
海外基金